NMPA Approval

Salviae Miltiorrhizae and Ligustrazine Hydrochloride Injection

Approval Number

国药准字H52020959

Company贵州拜特制药有限公司

Registration Date

September 21, 2015

Drug Information

Generic Name

丹参川芎嗪注射液

Dosage Form

注射剂

Strength

5ml

Drug Type

化学药品

Registration Date

September 21, 2015

Company Information

Applicant Company

Company Name贵州拜特制药有限公司

Company Address

贵州省贵阳市白云区麦架镇新材料产业园

Manufacturing Company

Company Name贵州拜特制药有限公司

Company Address

贵州省贵阳市白云区麦架镇新材料产业园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

丹参川芎嗪注射液 - NMPA 批准文号 | MedPath